Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OSTX OS Therapies Inc
- Stocks
- Healthcare
- NYSEAMERICAN: OSTX
Price (delayed)
$1.66
Market cap
$46.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.86
Enterprise value
$43.67M
OS Therapies Incorporated is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. Our mission is to address
Highlights
OS Therapies's debt has plunged by 100% YoY
The EPS has surged by 56% year-on-year and by 2.3% since the previous quarter
The equity has surged by 84% year-on-year but it has declined by 28% since the previous quarter
OS Therapies's net income has plunged by 53% YoY and by 27% from the previous quarter
The quick ratio has decreased by 30% QoQ
Key stats
What are the main financial stats of OSTX
Market
Valuations
Earnings
Shares outstanding
28.1M
Market cap
$46.64M
Enterprise value
$43.67M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$11.18M
Net income
-$11.3M
EBIT
-$10.08M
EBITDA
-$10.07M
Free cash flow
-$10.08M
Per share
Balance sheet
Liquidity
EPS
-$0.86
EPS diluted
-$0.86
Free cash flow per share
-$0.47
Book value per share
-$0.19
Revenue per share
$0
TBVPS
$0.2
Total assets
$4.25M
Total liabilities
$3.64M
Debt
$0
Equity
-$4.19M
Working capital
$559,091
Debt to equity
0
Current ratio
1.16
Quick ratio
0.84
Net debt/EBITDA
0.29
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-405%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-1,412.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OSTX stock price
How has the OS Therapies stock price performed over time
Intraday
4.4%
1 week
-2.35%
1 month
-18.63%
1 year
N/A
YTD
-61.21%
QTD
7.79%
Financial performance
How have OS Therapies's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.18M
Net income
-$11.3M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 185% YoY and by 64% from the previous quarter
OS Therapies's net income has plunged by 53% YoY and by 27% from the previous quarter
Price vs fundamentals
How does OSTX's price correlate with its fundamentals
Growth
What is OS Therapies's growth rate over time
Valuation
What is OS Therapies stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has surged by 56% year-on-year and by 2.3% since the previous quarter
The equity has surged by 84% year-on-year but it has declined by 28% since the previous quarter
Efficiency
How efficient is OS Therapies business performance
The ROA has grown by 44% YoY and by 8% from the previous quarter
Dividends
What is OSTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OSTX.
Financial health
How did OS Therapies financials performed over time
OS Therapies's total assets is 17% higher than its total liabilities
The total liabilities has plunged by 86% YoY and by 23% from the previous quarter
The quick ratio has decreased by 30% QoQ
OS Therapies's debt is 100% more than its equity
OS Therapies's debt has plunged by 100% YoY
OS Therapies's debt to equity has soared by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.